Post menopausal hormone therapy and mortality

New England Journal of Medicine

Volumn 336, Issue 25, 1997, Pages 1769-1775

  Grodstein, Francine ^a,b,c   Stampfer, Meir J ^a,b   Colditz, Graham A ^a,b   Willett, Walter C ^a,b   Manson, Joann E ^a   Joffe, Marshall ^b   Rosner, Bernard ^a,b   Fuchs, Charles ^a   Hankinson, Susan E ^a,b   Hunter, David J ^a,b   Hennekens, Charles H ^a,b   Speizer, Frank E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; BREAST TUMOR; CASE CONTROL STUDY; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; ESTROGEN THERAPY; MIDDLE AGED; MORTALITY; NEOPLASM; PROSPECTIVE STUDY; RISK;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CAUSE OF DEATH; CEREBROVASCULAR DISORDERS; CORONARY DISEASE; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; MORTALITY; NEOPLASMS; POSTMENOPAUSE; PROGESTINS; PROSPECTIVE STUDIES; RISK;

EID: 0030610461     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199706193362501     Document Type: Article

References (23)

1. Grady D, Rubin SM, Pctitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Mcd 1992; 117:1016-37.
2. Grodstcin F, Stampfer MJ. The epidemiology of coronary heart disease and estrogcn replacement in postmenopausal women. Prog Cardiovasc Dis 1995;38:199-210.
3. Bush TL, Cowan LD, Barrctt-Connor E, et al. Estrogen use and allcause mortality; preliminary results from the Lipid Research Clinics Program Follow-Up Study. JAMA 1983;249:903-6.
4. Hcnderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogcn replacement therapy. Arch Intern Med 1991;151:75-8.
5. Petitti DB, Perlman JA, Sidney S. Noncontraccptive estrogens and mor- tality: long-term follow-up of women in the Walnut Creek Study. Qbstet Gynccol 1987;70:289-93.
6. Folsom AR, Mink PJ, Sellers TA, Hong CP, Zheng W, Potter JD. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health 1995;85:112832.
7. Criqui MH, Suarcz L, Barrctt-Connor E, McPhillips J, Wingard DL, Garland C. Postmenopausal estrogen use and mortality: results from a prospective study in a defined, homogeneous community. Am J Epidemiol 1988;12S:606-14,
8. Sturgeon SR, Schaircr C, Brinton LA, PeartOfc T, Hoover RN. Evidence of a healthy estrogen user survivor effect. Epidemiology 1995;6:227-31.
9. Ettinger B, Fricdman GD, Bush T, Qucscnberry CP Jr. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 1996;87:6-12.
10. Vandcnbroucke JP. How much of the cardioprotective effect ofpostmenopausal estrogens is real? Epidemiology 1995;6:207-8.
11. Posthirma WFM, Westendorp RGJ, Vandenbroucke jp. Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? BMJ 1994;308:1268-9.
12. Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progcstin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-61. [Erratum, N Engl J Med 1996;335:1406.]
13. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of cstrogens and progestins and the risk of breast cancer in postmenopausal women. N EngJ J Mcd 1995;332:1589-93.
14. Willett WC, Stampfer MJ, Bain C, et al. Cigarette smoking, relative weight, and menopause. Am J Epidemiol 1983;117:651-8.
15. Stampfer MJ, Willett WC, Speizer FE, et al. Test of the National Death Index. Am J Epidemiol 1984;119:837-9.
16. National Center for Health Statistics. International classification of diseases: adapted for use in the United States. 8th rev. ICDA. Vol. 1. Tabular list. Washington, D.C.: Government Printing Office, 1967 (DHEW publication no. (PHS) 1693.)
17. Hosmer DW JR, Lemeshow S. Applied logistic regression. New York: John Wiley, 1989.
18. Grodstein F. Can selection bias explain the cardiovascular benefits of estrogen replacement therapy? Am J Epidemiol 1996;143:979-82.
19. Grodstein F, Martinez ME, Giovannucci EL, et al. Postmenopausal hormone use and colorectal cancer in the Nurses' Health Study. Am J Epidemiol 1996;143:Suppl:S63. abstract.
20. Calk EE, Miracle-McMahill HL, Thun MJ, Heath CW Jr. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort ofpostmenopausal women. J Natl Cancer Inst 1995;87:517-23.
21. Cauley JA, Cummings SR, Black DM, Mascioli SR, Sceley DG. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990;163:1438-44.
22. Barrctt-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991;115:455-6.
23. Colditz GA, Willett WC, Speizer FE. Breast cancer and hormonereplacement therapy. N Engl J Med 1995;333:1357-8.